Apontis Pharma AG (APPH) — Cash Flow-to-Debt Ratio
Apontis Pharma AG (APPH) has a Cash Flow-to-Debt Ratio of -0.16x as of June 2025, meaning its operating cash flow of €-1.94 Million could theoretically repay 0% of its total liabilities (€12.37 Million) in one year. See APPH free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Apontis Pharma AG Cash Flow-to-Debt Ratio (2019–2024)
Historical debt coverage capacity for Apontis Pharma AG across 6 annual periods. Also explore Apontis Pharma AG net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Apontis Pharma AG (2019–2024)
Year-by-year debt coverage analysis for Apontis Pharma AG. For market capitalisation and broader financial context, see market cap of Apontis Pharma AG.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.22x | €-2.90 Million | €13.36 Million | ▲ +53.1% |
| 2023 | -0.46x | €-12.60 Million | €27.20 Million | ▼ -176.9% |
| 2022 | 0.60x | €11.02 Million | €18.29 Million | ▲ +135.5% |
| 2021 | 0.26x | €3.43 Million | €13.42 Million | ▲ +362.5% |
| 2020 | 0.06x | €1.45 Million | €26.23 Million | ▲ +702.8% |
| 2019 | -0.01x | €-238.07K | €25.94 Million | — |